Prime Medicine Inc. (PRME)
NASDAQ · Healthcare
Prime Medicine Inc. Operating Income 2020–2025
Prime Medicine Inc. annual/quarterly operating income history and growth rate from 2020 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Prime Medicine Inc. operating income for the quarter ending September 30, 2025 was -54.0 M, a 0.48% decrease year-over-year.
- Prime Medicine Inc. operating income for the twelve months ending September 30, 2025 was -214.0 M, a 6.60% increase year-over-year.
- Prime Medicine Inc. annual operating income for 2025 was -208.3 M, a 2.91% increase from 2024.
- Prime Medicine Inc. annual operating income for 2024 was -202.5 M, a 1.14% decrease from 2023.
- Prime Medicine Inc. annual operating income for 2023 was -204.8 M, a 75.72% increase from 2022.
- Prime Medicine Inc. annual operating income for 2022 was -116.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Prime Medicine Inc. Operating Income — FAQ
Prime Medicine Inc. (PRME) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Prime Medicine Inc.'s operating income?
Prime Medicine Inc. (PRME) reported operating income of -$208M for fiscal 2025.
Where can I see PRME's operating income history?
The chart and table above show Prime Medicine Inc.'s operating income by year and by quarter, including the growth rate.